Gilead Sciences, Inc.Foster City, California, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
83 - Predictors of Undetectable HDV RNA 48 weeks after completion of finite treatment with Bulevirtide and Pegylated-Interferon Alpha 2a
Thursday, October 17, 202410:45 AM – 11:00 AM US PT
